mRNA vaccines, which were praised during the COVID-19 pandemic as a breakthrough in biotechnology, are now facing a period of uncertainty as government agencies and pharmaceutical companies scale back funding.
mRNA vaccines are a type of vaccine that uses a synthetic piece of genetic code, mRNA, to instruct a cell in the body to produce a particular protein. The development of these vaccines accelerated during the COVID pandemic.
“Not enough money was put into the mRNA vaccines… but suddenly something happened, which flooded money into it, and that was COVID,” biotechnology teacher Mr. Timothy Styer said. “There was no vaccine, and we needed one… a blank check appeared.”
However, on August 5, 2025, the U.S. Department of Health and Human Services (HHS) declared that the Biomedical Advanced Research and Development Authority (BARDA) will begin its coordinated effort to wind down the funding for mRNA vaccine development.
A report arguing that the proteins generated by mRNA vaccines may potentially cause harm was cited as the reason for this defunding.
“Vaccines have caused issues in the past…we’ve recorded them to see how we can get around them,” Styer said. “Does that mean do away with vaccines because there’s a slight risk? Do you not drive because you may have an accident?”
Regardless of the risk being minute, the defunding effort began with the termination of 22 mRNA vaccine development investments, and nationally, many research programs have stopped or have been defunded or put on hold. The leverage of funding has other consequences as well.
“By withholding all federal funding, which amounts to billions, you’re getting [institutions] to do what you want, which is coercion,” Styer said.
This regulation is not simply a policy shift, but a testament to how short-term politics can reshape the ability to innovate in the long term.
“There’s a direct correlation here. The amount of funding results in discoveries, in preventatives, in therapeutics, in medicines, and all of that,” Styer said. “You take away funding from the government, which means we’re going to rely solely on private funding, and private can’t do it. Private goes to other things, too.”
For the labor workforce, the defunding of the mRNA vaccines’ impact can be seen for those who aspire in drug development. There are concerns that defunding the mRNA vaccine research will hinder the US’ ability to respond to future outbreaks.
“I want to go into drug development or maybe clinical trials when I grow up… if we cut research, we’re not going to get better at creating vaccines quickly for times of crisis,” freshman Isabella Bittman said.
This wave of instability worries students, too, about what research and development may look like in the future.
“This does make me a little worried, because without these important funds for research, we’re not gonna make improvements or find out new things about drug development,” Bittman said.
mRNA vaccines have had a variety of applications, including showcasing potential to improve cardiac function, suppress allergies, and even lead to a vaccine to fight against cancer, however, this lack of funding is a huge burden for researchers to continue exploring these issues.
“We know we can do these things, but it’s going to take time to get there. It’s going to take research funding to get there. To cut that is very frustrating…it’s only done because of misinformation,” Styer said.
Regardless, this burden should be seen as a temporary pause, not a permanent one, and should act to inspire researchers to work harder towards the goal, and towards continuing research, discovery, innovation, and science.
“Is [the defunding] making you feel like ‘Why bother?’ or is it putting fuel in your fire?” Styer said. “I hope you feel empowered. I hope you feel angry. I hope you feel like it’s time to step up and do something about it… not letting it affect what you want to do with your life or your major in college. Maybe it will be frustrating enough to encourage people to go in that direction and not be discouraged.”
